On 12/31/2020, at approximately 00:15, pt developed a fever of 102.9 F and tachycardia with rate of 120. He was treated with acetaminophen. Later in the morning, he complained of nausea, generalized muscle

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (MODERNA))

SYMPTOM(S):

• Pyrexia, 
• Oedema, 
• Myalgia, 
• Vomiting, 
• Dyspnoea, 
• Nausea, 
• Abdominal pain, 
• Pancreatitis, 
• Confusional state, 
• Tachycardia, 
• Diarrhoea, 
• Sepsis, 
• Electrocardiogram abnormal, 
• Atrial fibrillation, 
• Pulmonary embolism, 
• Ascites, 
• Hepatic cirrhosis, 
• Sinus tachycardia, 
• Tachypnoea, 
• White blood cell count decreased, 
• Culture urine positive, 
• Haematocrit decreased, 
• Haemoglobin decreased, 
• Platelet count decreased, 
• Red blood cell count decreased, 
• Fall, 
• Blood potassium decreased, 
• Acute respiratory distress syndrome, 
• C-reactive protein increased, 
• Hiatus hernia, 
• Chronic obstructive pulmonary disease, 
• Blood culture negative, 
• International normalised ratio increased, 
• Blood lactic acid, 
• Computerised tomogram abdomen abnormal, 
• Lipase normal, 
• Brain natriuretic peptide normal, 
• Computerised tomogram thorax abnormal, 
• Scan with contrast, 
• Procalcitonin increased, 
• Arteriosclerosis coronary artery, 
• Portal hypertension, 
• Lung opacity, 
• Splenic granuloma

54 y/o M with PMH of HTN, HLD, Alcoholic Cirrhosis, Aortic Valve Stenosis, and angina BIBA as a Medical Alert for cardiac arrest noted PTA. Per EMS, the patient called because he was having constant, diffuse

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Abdominal pain, 
• Pain, 
• Chest pain, 
• Cardiac arrest, 
• Pulse absent, 
• Resuscitation

71 year old woman at rehabilitation center for physical therapy with history of cirrhosis of the liver, asthma, and heart condition was tested for COVID-19 on 01/07/21, received 1st dose of Pfizer COVID-19

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Confusional state, 
• Death

tightness of shoulders and neck; tightness of shoulders and neck; started having severe nausea in the last hour; Has a slight headache; This is a spontaneous report from a contactable consumer (patient

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Headache, 
• Nausea, 
• Musculoskeletal stiffness, 
• Muscle tightness

felt tired; nausea; headache; short of breath; rapid/shallow breathing; rapid/shallow breathing; fast heart rate (100 bpm); low grade fever; felt very weak; pleuralpericardial effusion; pleuralpericardial

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Pyrexia, 
• Headache, 
• Dyspnoea, 
• Nausea, 
• Asthenia, 
• Electrocardiogram abnormal, 
• Pleural effusion, 
• Pericardial effusion, 
• Fatigue, 
• Heart rate increased, 
• Respiratory rate increased, 
• X-ray abnormal, 
• Angiogram, 
• Angiogram abnormal, 
• Hypopnoea, 
• SARS-CoV-2 test negative

cirrhosis of the liver; Low platelets; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer. A female patient of an unspecified age received her first dose of BNT162B2

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Hepatic cirrhosis, 
• Platelet count decreased

After 1st COVID-19 injection started with vaginal discharge spotting; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received first dose of

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Vaginal discharge

Patient was coded and expired Code Blue: Patient was in dialysis, after 30 minutes his sbp dropped to 60s he was given 4 albumin. Patient who was responsive before that became unresponsive, had seizure

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Ventricular fibrillation, 
• Gastrointestinal haemorrhage, 
• Unresponsive to stimuli, 
• Respiratory arrest, 
• Death, 
• Cardio-respiratory arrest, 
• Pulse absent, 
• Aspiration, 
• Endotracheal intubation, 
• Mechanical ventilation, 
• Resuscitation, 
• Dialysis, 
• Blood pressure systolic decreased, 
• Seizure like phenomena, 
• Pulseless electrical activity

The patient was admitted to the hospital on February 10, 2021 for evaluation of jaundice. This is a healthcare worker (direct patient care) and she received the first dose of Covid 19 vaccine in January

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (PFIZER-BIONTECH))

SYMPTOM(S):

• Chills, 
• Rash, 
• Abdominal pain, 
• Hyperhidrosis, 
• Diarrhoea, 
• Rash maculo-papular, 
• Alanine aminotransferase increased, 
• Jaundice, 
• Aspartate aminotransferase increased, 
• Petechiae, 
• Cholelithiasis, 
• Antinuclear antibody, 
• Splenomegaly, 
• Thrombocytopenia, 
• Hepatomegaly, 
• Epistaxis, 
• Blood alkaline phosphatase increased, 
• Monocytosis, 
• Hepatic cirrhosis, 
• Microcytic anaemia, 
• Proctitis, 
• Colitis ulcerative, 
• Decreased appetite, 
• Platelet count decreased, 
• Hepatic enzyme abnormal, 
• Blood bilirubin increased, 
• Monocyte count increased, 
• Blood immunoglobulin M, 
• Computerised tomogram abnormal, 
• Hepatitis C antibody negative, 
• Ultrasound scan abnormal, 
• Antineutrophil cytoplasmic antibody, 
• Hepatitis B surface antigen negative, 
• Epstein-Barr virus test, 
• Biopsy liver abnormal, 
• Ocular icterus, 
• Cytomegalovirus test, 
• Bilirubin conjugated increased, 
• Lip haemorrhage, 
• Prurigo, 
• Hepatitis A antibody, 
• Smooth muscle antibody negative, 
• Autoantibody negative, 
• Antimitochondrial antibody normal, 
• Hepatitis B core antibody negative, 
• Hepatitis B surface antibody positive, 
• Portal hypertension, 
• SARS-CoV-2 test negative, 
• Non-alcoholic steatohepatitis, 
• Occupational exposure to SARS-CoV-2, 
• Magnetic resonance imaging abdominal abnormal, 
• Gastric varices, 
• Portal hypertensive gastropathy, 
• Splenic varices

developed cirrhosis; scalp infection; Headache; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed cirrhosis,

VACCINE TYPE(S):

• COVID19

VACCINE NAME(S):

• COVID19 (COVID19 (MODERNA))

SYMPTOM(S):

• Headache, 
• Skin disorder, 
• Hepatic cirrhosis